Myelin Protein Zero (MPZ) Monoclonal Antibody (CAB21931)
The Myelin Protein Zero (MPZ) Monoclonal Antibody (CAB21931) is a high-quality antibody developed for reliable detection and analysis of target proteins. The monoclonal antibody, raised in mice, is highly specific and reliable for detecting MPZ in human samples, making it an invaluable asset for studies in neurology and neuroscience.MPZ, also known as P0 protein, is a major component of myelin in the peripheral nervous system, essential for the insulation and proper functioning of nerve fibers. Dysregulation or mutations in the MPZ gene have been linked to various neurological disorders, including Charcot-Marie-Tooth disease and other demyelinating neuropathies.
This antibody is validated for use in WB, ELISA applications and has demonstrated reactivity against Mouse, Rat samples.
Product Name:
Myelin Protein Zero (MPZ) Monoclonal Antibody
SKU:
CAB21931
Size:
20μL, 100μL
Reactivity:
Mouse, Rat
Clone Number:
ARC53696
Conjugate:
Unconjugated
Immunogen:
Synthetic peptide. This information is considered to be commercially sensitive.
Recommended starting concentration is 1 μg/mL. Please optimize the concentration based on your specific assay requirements.
Synonyms:
P0, CHM, DSS, MPP, CHN2, CMT1, CMT1B, CMT2I, CMT2J, CMT4E, CMTDI3, CMTDID, HMSNIB, Myelin Protein Zero (MPZ)
Positive Sample:
Mouse Skeletal muscle, Rat Skeletal muscle
Cellular Localization:
Cell Membrane, Myelin Membrane, Single-Pass Type I Membrane Protein.
Calculated MW:
28kDa
Observed MW:
28kDa
This gene is specifically expressed in Schwann cells of the peripheral nervous system and encodes a type I transmembrane glycoprotein that is a major structural protein of the peripheral myelin sheath. The encoded protein contains a large hydrophobic extracellular domain and a smaller basic intracellular domain, which are essential for the formation and stabilization of the multilamellar structure of the compact myelin. Mutations in this gene are associated with autosomal dominant form of Charcot-Marie-Tooth disease type 1 (CMT1B) and other polyneuropathies, such as Dejerine-Sottas syndrome (DSS) and congenital hypomyelinating neuropathy (CHN). A recent study showed that two isoforms are produced from the same mRNA by use of alternative in-frame translation termination codons via a stop codon readthrough mechanism.
Purification Method
Affinity purification
Gene ID
4359
Buffer Information
Store at -20℃. Avoid freeze / thaw cycles. Buffer: PBS containing 50% glycerol and 0.05% BSA, preserved with proclin300 or sodium azide, pH 7.3.
Western blot analysis of various lysates using Myelin Protein Zero (MPZ) Rabbit mAb (CAB21931) at1:19000 dilution. Secondary antibody: HRP-conjugated Goat anti-Rabbit IgG (H+L) (CABS014) at 1:10000 dilution. Lysates/proteins: 25μg per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit (AbGn00020). Exposure time: 60s.
